Posted inResearch
CRO and clinical trial markets set for growth by 2030, especially in Asia-Pacific region: reports
The global CRO market is projected to hit almost $63 billion by the end of the decade, growing an average…
Posted inResearch
Health tech company myTomorrows cuts ribbon at India operations hub, looks to expand clinical trial access in Asia
Amsterdam-based health tech company myTomorrows is eyeing expansion into the Asia-Pacific region, opening an operations hub in India that will…
Posted inResearch
EQBMED launches trial sites tool to assess performance and boost diversity
The academic-led, industry-partnered collaboration Equitable Breakthroughs in Medicine Development (EQBMED) has released an assessment tool for clinical trial sites to…
Posted inResearch
AI model matches patients to trials almost as accurately as humans: study
To recruit volunteers more quickly for clinical trials, a team of National Institutes of Health (NIH) researchers has turned to…
Posted inResearch
CRO Lindus Health launches latest ‘all-in-one’ service for infectious disease clinical trials
Lindus Health has gone all-in on all-in-one CRO offerings. Less than a month after launching its All-in-One Women's Health CRO…
Posted inResearch
New Jersey biopharmas take pledge to give employees paid time off for participating in clinical trials
After an impassioned plea from a patient advocate at BioNJ’s annual dinner and innovation celebration in February, the trade organization…
Posted inResearch
Canadian CRO Innovaderm looks to expand in Europe with new vice president
Canadian CRO Innovaderm is looking to expand its operations across the pond with the hiring of Ina Zschocke, Ph.D., as…
Posted inResearch
Sanofi, Formation and OpenAI design AI tool to slash clinical trial timelines
There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed…
Posted inResearch
Medable adds generative AI to clinical trial platform to speed up creation of outcome assessments
Medable is bringing generative AI into its clinical trial platform in hopes that the tech will reduce the burden of…
Posted inResearch
Charles River continues slide in Q3 as CEO spots reduced spending by biopharma clients
Charles River has been riding rough waters in 2024, and, as the CRO’s CEO predicted, the third quarter proved no…